0 results available. Select is focused ,type to refine list, press Down to open the menu,
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...
We've identified the following companies as similar to Novartis AG ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
Name | Ticker | EPS Forecast Median Consensus |
---|---|---|
Merck & Co., Inc. | BRSE:010683053 | - |
AstraZeneca PLC | BRSE:000982352 | - |
Johnson & Johnson | BRSE:000943981 | - |
Pfizer Inc | DB:PFE | - |
Eli Lilly and Co | SWX:LLY | - |
Bristol-Myers Squibb Co | BRSE:BMY | - |
Teva Pharmaceutical Industries Limited | SWX:TEVA | - |
GlaxoSmithKline PLC | BRSE:001102657 | - |
Healthcare | SECTOR:HLTH.CH | 1.71 |
Sandoz Group AG | SWX:SDZ | 2.77 |
Novartis AG ADR | NYSE:NVS | 8.41 |
Roche Holding AG | SWX:RO | 20.58 |
To view the full list of supported financial metrics please see Complete Metrics Listing.
The median EPS Forecast submitted by any analyst for the company.
The chart above depicts the distribution of eps forecast median consensus for companies operating in the Healthcare sector in the Developed economic region. Over 1,590 companies were considered in this analysis, and 1,528 had meaningful values. The average eps forecast median consensus of companies in the sector is -0.55 with a standard deviation of 4.87.
Novartis AG ADR's EPS Forecast Median Consensus of 8.41 ranks in the 95.9% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 1,592 |
Included Constituents | 1,528 |
Min | -36.08 |
Max | 19.18 |
Median | -0.20 |
Mean | -0.55 |
Standard Deviation | 4.87 |
You can find companies with similar eps forecast median consensus using this stock screener.